Back

Cancer drives atherosclerotic plaque vulnerability by inducing pathological angiogenesis

Luo, L.; Fu, C.; Jarr, K.-U.; Baylis, R.; Sun, V. H.; Heemelaar, J.; von Scheidt, M.; Ramirez, D.; Krefting, J.; Sachs, N.; Wettich, J. L.; Winter, H.; Gao, H.; Wang, F.; Adkar, S.; Haas, A.; Gonzalez, M.; Nead, K. T.; Maegdefessel, L.; Schunkert, H.; Neilan, T. G.; Leeper, N. J.

2026-01-20 pathology
10.64898/2026.01.18.700232 bioRxiv
Show abstract

Cardiovascular disease (CVD) is the leading cause of death for many cancer survivors, a phenomenon traditionally attributed to shared risk factors and cardiotoxic chemotherapies. Here, we hypothesized that cancer may also directly promote atherosclerosis. Propensity-matched analyses confirmed significantly elevated cardiovascular event rates amongst cancer patients, independent of comorbidities such as smoking. Atheroprone mice implanted with colorectal tumors demonstrated accelerated features of plaque vulnerability, driven by pathological angiogenesis and intraplaque hemorrhage. Mechanistically, tumor-secreted TNF- induced the pro-angiogenic factor LRG1 across multiple murine models and human plaques. Therapeutic interventions targeting these pathways, including with FDA-approved cytokine inhibitors or tumor resection, prevented plaque destabilization in mice and reduced coronary revascularization rates in patients. Together, these findings suggest that cancer may causally promote CVD and unveil novel translational strategies for cancer survivors.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.